Wir sind mit live! Mehr erfahren

Utah Medical Products

UTMD

Börsenwert 236 Mio. $

74,51 USD

-0,41

0,55 %

Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT

1 Tag

-0,55 %

5 Tage

-0,09 %

1 Monat

0,61 %

3 Monate

3,86 %

6 Monate

7,13 %

Seit Jahresbeginn

31,88 %

1 Jahr

24,02 %

5 Jahre

-16,36 %

10 Jahre

22,55 %

Profil: Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

Mitarbeiter: 152

Gesundheitswesen Medizinische Geräte und Verbrauchsmaterialien

Nachrichten

Positiv

Neutral

Negativ

Stimmung 3 Monate

Positiv 11,1 %

Neutral 77,8 %

Negativ 11,1 %

Zacks Investment Research

UTMD Trades at a Premium to the Industry: How to Play the Stock?

Utah Medical's Orion acquisition, strong cash reserves, improving margins and product expansion efforts support growth prospects and continued shareholder returns.

UTMD Trades at a Premium to the Industry: How to Play the Stock?

Utah Medical Products, Inc. Extends Tender Offer

SALT LAKE CITY, UT / ACCESS Newswire / October 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The Offer was initially scheduled to expire at 5:00 p.m.

Utah Medical Products, Inc. Extends Tender Offer

Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date

SALT LAKE CITY, UT / ACCESS Newswire / September 25, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC at https://www.sec.gov/Archives/edgar/data/706698/000109690626001428/0001096906-26-001428-index.html The Offer is scheduled to expire at 5:00 p.m.

Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date

Utah Medical Products, Inc. Commences Tender Offer

SALT LAKE CITY, UT / ACCESS Newswire / September 24, 2026 / Utah Medical Products, Inc. (NASDAQ:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The $75.00 per share price represents a 17% premium over the average daily closing price of the stock during the last twelve months, and a 21% premium over the average daily closing price of the stock during the last twenty-four months.

Utah Medical Products, Inc. Commences Tender Offer

UTMD Announces Self-Tender for 20% of Its Shares

SALT LAKE CITY, UT / ACCESS Newswire / September 15, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces today that it intends to repurchase at a price of $75.00 per share up to 650,000 of its shares, if tendered and not withdrawn by stockholders on or before October 7, representing approximately 20% of its currently outstanding shares. The offering price is 17% higher than the average daily closing price of UTMD shares trading in the open market during the last twelve months, and 21% higher than the average daily closing price of UTMD shares trading during the last two years.

UTMD Announces Self-Tender for 20% of Its Shares

Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK

SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of Utah Medical Products, Inc. (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.

Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK

Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.

Utah Medical Products, Inc. Announces Quarterly Dividend

Zacks Investment Research

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026

SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same time periods in 2025. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026

Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.

Utah Medical Products, Inc. Announces Quarterly Dividend

Nachrichtenrankings ansehen

Kursdiagramme mit Lightweight Charts™ umgesetzt